Cannell & Co. Eli Lilly & CO Transaction History

Cannell & Co.

$3.01 Billion
Q4 2023

A detailed history of Cannell & Co. transactions in Eli Lilly & CO stock. As of the latest transaction made, Cannell & Co. holds 672 shares of LLY stock, worth $595,351. This represents 0.01% of its overall portfolio holdings.

Number of Shares

672

Previous 405 65.93%

Holding current value

$595,351

Previous $217,000 80.18%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$525.19 - $619.13 $140,225 - $165,307	267 Added 65.93%	672 $391,000
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $662,917 - $913,932	-1,525 Reduced 79.02%	405 $217,000
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $8,768 - $11,724	25 Added 1.31%	1,930 $905,000
Q1 2023 May 08, 2023	SELL	$310.63 - $364.82 $29,509 - $34,657	-95 Reduced 4.75%	1,905 $654,000
Q4 2022 Feb 03, 2023	BUY	$321.55 - $374.67 $9,646 - $11,240	30 Added 1.52%	2,000 $731,000
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $8,361 - $9,818	-30 Reduced 1.5%	1,970 $639,000
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $6,523 - $8,631	-50 Reduced 2.44%	2,000 $338,000
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $7,311 - $8,456	-50 Reduced 2.38%	2,050 $303,000
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $11,079 - $12,932	-100 Reduced 4.55%	2,100 $233,000
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $838,720 - $987,235	-7,535 Reduced 77.4%	2,200 $285,000
Q3 2018 Nov 05, 2018	SELL	$85.86 - $107.31 $8,586 - $10,731	-100 Reduced 1.02%	9,735 $1.05 Million
Q3 2017 Nov 08, 2017	BUY	$77.07 - $85.54 $757,983 - $841,285	9,835	9,835 $841,000

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $842B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

News

Stay updated on Cannell & Co. with notifications on news.

Account